PRMT5 and colorectal cancer: To further investigate the enzyme activity of PRMT5 was required or not for the colorectal cancer cell proliferation, we used GSK591, a PRMT5 specific inhibitor, to treat HCT116 cells, and the SDMA expression was assessed.